Adhesion molecules in the dissemination of non-hodgkin’s lymphomas

Acta Haematologica

Volumn 97, Issue 1-2, 1997, Pages 73-80

  Pals, Steven T ^a   Drillenburg, Paul ^a   Radaszkiewicz, Thaddaus ^b   Manten Horst, Eveliene ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adhesion; CD44; Integrin; Lymphoma; Metastasis

Indexed keywords

CELL ADHESION MOLECULE; CELL RECEPTOR; HERMES ANTIGEN; L SELECTIN; LYMPHOCYTE ANTIGEN;

EPITHELIUM; HUMAN; LYMPH NODE; LYMPHOCYTE; METASTASIS; MUCOSA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; SKIN; SOLID TUMOR;

ANTIGENS, CD44; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; HUMANS; LIGANDS; LYMPHOCYTES; LYMPHOMA, NON-HODGKIN; NEOPLASM METASTASIS; NEOPLASM PROTEINS; ORGAN SPECIFICITY; RECEPTORS, LYMPHOCYTE HOMING;

EID: 14444270350     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203662     Document Type: Article

References (77)

1. Springer TA: Adhesion receptors of the immune system. Nature 1990;346:425-434.
2. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994:76:301-314.
3. Picker LJ, Butcher EC: Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 1992;10:561-591.
4. Herrlich P, Zoller M, Pals ST, Ponta H: CD44 splice variants: Métastasés meet lymphocytes. Immunol Today 1993;14:395-399.
5. Williams AF, Barclay AN: The immunoglobulin superfamily-domains for cell-surface recognition. Annu Rev Immunol 1988:6:381-405.
6. Hemler ME, Elices MJ, Parker C, Takada Y: Structure of the integrin VLA-4 and its cell-cell and ccll-matrix adhesion functions. Immunol Rev 1990;114:45-65.
7. Hynes RO: Integrins: Versatility, modulation, and signalling in cell adhesion. Cell 1992;69: 11-25.
8. Stoolman LM: Adhesion molecules controlling lymphocyte migration. Cell 1989;56:907-910.
9. Stamenkovic I, Amiot M, Pesando JM, Seed B: A lymphocyte molecule implicated in lymphocyte homing is a member of the cartilage link protein family. Cell 1989;56:1057-1062.
10. Günthert U, Hofmann M, Rudy W. Reber S, Zoller M. Haussmann I, Matzku S, Wenzel A. Ponta H, Herrlich P: A new variant of CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
11. Pals ST, Koopman G, Griffioen AJ, Ponta H, Herrlich P, van der Berg F, Horst E: CD44: A variety of isoforms with functions in cell adhesion and metastasis; in Shimizu Y (ed): Lymphocyte Adhesion Molecules. Austin, Landis, 1993, pp 135-151.
12. Lub M, Kooyk Y, Figdor CG: Ins and outs of LFA-1. Immunol Today 1995;16:479-482.
13. Butcher EC: Leucocyte-endothelial cell recognition: Three (or more) steps to specificity or diversity. Cell 1991;67:1033-1036.
14. Shimizu Y, Newman W, Tanaka Y. Shaw S: Lymphocyte interaction with endothelial cells. Immunol Today 1992:13:106-112.
15. Koopman G, van Kooyk Y, de Graaff M, Meyer CJLM, Figdor CG, Pals ST: Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J Immunol 1990;145:3589-3593.
16. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-Ip. Nature 1993;361:79-82.
17. Mackay CR: T-cell memory: The connection between function, phenotype and migration pathways. ImmunolToday 1991;12:189-192.
18. Pals ST, Horst E, Schcper RJ, Meijer CJLM: Mechanisms of human lymphocyte migration and their role in the pathogenesis of disease. Immunol Rev 1989;108:111-133.
19. Hamann A, Andrew DP. Jablonski-Westrich D, Holzmann B, Butcher EC: Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol 1994;152:3282-3293.
20. Arbones ML, Ord DC, Ley K, Ratech H, May-nard-Curry C, Otten G, Capon DJ, Tedder TF: Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994:1:247-260.
21. Pals ST, Meijer CJLM, Radaszkiewicz T: Expression of the human peripheral lymph node homing receptor (LECAM-1) in nodal and gastrointestinal non-Hodgkin’s lymphomas. Leukemia 1991;5:628-631.
22. Mollcr P, Eichelmann A. Mechtersheimer G, Koretz K: Expression of 5-1 integrins, H-CAM (CD44), and LECAM-1 in primary gastrointestinal B-cell lymphomas as compared to the adhesion receptor profile of the gut associated lymphoid system, tonsil and peripheral lymph node. Int J Cancer 1991;49:846-855.
23. Abel EA, Wood GS, Hoppe RT. Warnke RA: Expression of Leu-8, a majority T-cell marker, is uncommon in mycosis fungoides. J Invest Dermatol 1985;85:199-202.
24. Pals ST. Drillcnburg P. Dragosics B. Lazarovits AI, Radaszkiewicz T: Expression of the mucosal homing receptor 04(37 in malignant lympho-matous polyposis of the intestine. Gastroenterology 1994;107:1519-1523.
25. Duijvcstijn AM, Horst E, Pals ST, Rouse BN, Steere AC, Picker LJ, Meijer CJLM, Butcher EC: High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol 1988;130:147-155.
26. Picker LJ, Michie SA, Rott LS, Butcher EC: A unique phenotype of skin associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990:136: 1053-1068.
27. Schweighoffer T, Tanaka Y, Tidswell M, Erie DJ, Horgan KJ, Luce GE, Lazarovits AI, Buck D, Shaw S: Selective expression of integrin eußz on a infset of human CD4+ memory T cells with hallmarks of gut-tropism. J Immunol 1993;151:717-729.
28. Bos JD, de Boer OJ, Tibosch E, Das PK, Pals ST: Skin homing T lymphocytes: Detection of cutaneous lymphocyte associated antigen (CLA) by HECA-452 in normal human skin. Arch Dermatol Res 1993;285:179-183.
29. de Boer OJ, Horst E. Pals ST, Bos JD, Das PK: Functional evidence that the HECA-452 antigen is involved in the adhesion of human neutrophils and lymphocytes to tumour necrosis factor-alpha-stimulated endothelial cells. Immunology 1994:81:359-365.
30. Berg EL, Yoshino T, Rott LS. Robinson MK. Warnock RA, Kishimoto TK, Picker L. Butcher EC: The cutaneous lymphocyte antigen is a skin homing receptor for the vascular lectin endothelial cell-leukocytc adhesion molecule 1. J Exp Med 1991;174:1461-1466.
31. Meijer CJLM, Beljaards R, Horst E. Willemze R, van der Valk P, Pals ST: Differences in antigen expression between primary cutaneous and node based T-cell lymphomas. J Invest Dermatol 1989,92:479.
32. Koopman G, Pals ST: Cellular interactions in the germinal center: Role of adhesion receptors and significance for the pathogenesis of AIDS and malignant lymphoma. Immunol Rev 1992; 126:21-45.
33. Haskard D, Cavendcr D. Beatty P. Springer T, Ziff M: T-lymphocyte adhesion to endothelial cells: Mechanisms demonstrated by anti-LFA-1 antibodies. J Immunol 1986; 137:2901- 2906.
34. Scheeren RA. Koopman G, van der Baan S, Mcijer CJLM, Pals ST: Adhesion receptors involved in early clustering of blood dendritic cells and T-lymphocytes. Eur J Immunol 1991: 21:1101-1105.
35. Singer KH. Tuck DT. Sampson HA, Hall RP: Epidermal kcratinocytes express the adhesion molecule intercellular adhesion molecule-1 in inflammatory dermatoses. J Invest Dermatol 1989:92:746-750.
36. Roossien FF. de Rijk D, Bikker A, Roos E: Involvement of LFA-1 in lymphoma invasion and metastasis demonstrated with LFA-1 deficient mutants. J Cell Biol 1989;108:1979-1985.
37. Roos E: Adhesion molecules in lymphoma metastasis. Cancer Metastasis Rev 1991;10:33-48.
38. Haming R,: Monoclonal antibodies to lymphocyte-function-associated antigen-1 inhibit invasion of human lymphoma and metastasis of murine lymphoma. Clin Exp Metastasis 1993; 1 1:337-342.
39. Horst E, Radaszkiewicz T. Hooftman-den Otter A. Pieters R. van Dongcn JJM, Mcijer CJLM, Pals ST: Expression of the leukocyte integrin LFA-1 (CDlla/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade. Leukemia 1991;5:848-853.
40. Medeiros LJ, Weiss LM. Picker LJ, Clayberger C, Homing SJ, Krcnsky AM, Warnke RA: Expression of LFA-1 in non-Hodgkin’s lymphoma. Cancer 1989:63:255-259.
41. Horst E. Meijer CJLM, Radaszkiewicz T, Ossekoppele GJ, van Krieken JHJM, Pals ST: Adhesion molecules in the prognosis of diffuse large-cell lymphoma: Expression of a lymphocyte homing receptor (CD44), LFA-1 (CD1 la/ CD18), and ICAM-1 (CD54). Leukemia 1990; 4:595-599.
42. van Dinther-Janssen ACHM. Horst E, Koopman G, Scheeper RJ, Newman W. Meijer CJLM, Pals ST: The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. J Immunol 1991;147:4207-4210.
43. 4pi integrin. Nature 1992;356:63-66.
44. 4 inte-grin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993:177: 57-68.
45. Mollcr P. Eichclmann A. Mcchtcrsheimcr G: Adhesion molecules VLA-1 to VLA-6 define discrete stages of peripheral B lymphocyte development and characterize different types of B cell neoplasia. Leukemia 1992;6:256-264.
46. Briskin MJ, McEvoy LM, Butcher EC: MAd-CAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA 1. Nature 1993;363:461-464.
47. Holzmann B. McIntyre BW, Weissman IL: Identification of a murine Peyer’s patch-specific lymphocyte homing receptor as an inte-grin molecule with an a chain homologous to human VLA-4a. Cell 1989;56:37-46.
48. Parker CM, Cepek KL, Russell GJ, Shaw SK, Prosnctt DN, Schwarting RL, Brenner MB: A family of P7 integrals on human mucosal lymphocytes. Proc Natl Acad Sci USA 1992;89: 1924-1928.
49. Ep7 integrin. Nature 1994:372:190-193.
50. Ep7 integrin in cutaneous T-cell lymphoma. Am J Path 1994:145: 1148-1158.
51. Lesley J. Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 1993;54:271-335.
52. Trowbridge IS, Lesley J, Schulte R. Hyman R, Trotter J: Biochemical characterization and cellular distribution of a polymorphic, murine ccll-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 1982; 15:299-312.
53. Carter WG. Wayner EA: Characterization of the class III collagen receptor, a phosphorylat-ed, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 1988;263: 4193-4201.
54. Jalkanen S. Bargatze RF, Herron LR, Butcher EC: A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 1986: 16:1195-1202.
55. Stamenkovic I. Aruffo A, Amiot M. Seed B: The hematopoietic and epithelial forms of CD44 arc distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EM BO J 1991;10:343-384.
56. Haynes BF, Telcn MJ. Hale PL. Denning SM: CD44-A molecule involved in leukocyte adherence and T cell activation. Immunol Today 1989;10:423-428.
57. Wielenga VJM, Hcider KH. Offerhaus GJA, Adolf GR. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993:53:4754-4756.
58. Koopman G. Heider KH, Horst E, Adolf GR. van den Berg F, Ponta H, Herrlich P. Pals ST: Activated human lymphocytes and non-Hodg-kin’s express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993: 177:897-904.
59. Miyake K, Medina KL. Hayashi S, Ono S. Hamaoka T. Kincade PW: Monoclonal antibodies to Pgp-1/CD44 block lympho-hemo-poiesis in long-term bone marrow cultures. J Exp Med 1990;171:477-488.
60. Sy MS. Guo YJ, Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 1991:174:859-866.
61. Pals ST, Horst E. Ossekoppele GJ, Figdor CG, Schcper RJ. Mcijer CJLM: Expression of lymphocyte homing receptor (CD44) as a mechanism of dissemination in non-Hodgkin’s lymphoma. Blood 1989;73:885-888.
62. Jalkanen S. Joensuu H, Söderström KO. Klemi P: Lymphocyte homing and the clinical behavior of non-Hodgkin's lymphomas. J Clin Invest 1991;87:1835-1840.
63. Scrcaton GR, Bell MV. Jackson DG. Cornelius FB, Gcrth U. Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89:12160-12164.
64. Heider KH, Hofmann M. Horst E., van den Berg F. Ponta P. Herrlich P. Pals ST: A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993;120:227-233.
65. Mackay CR, Terpe HJ, Stauder R. Marston WL, Stark H, Gunlhert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994:124:71-82.
66. Fox SB. Fawcett J. Jackson DG, Collins I. Gat-ter KC. Harris AL, Gearing A. Simmons DL: Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994;54:4539-4546.
67. Arch R, Wirth K, Hofman M, Ponta H, Matz-ku S, Herrlich P, Zoller M: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992; 257:682-685.
68. Horst E, Mcijcr CJLM, Radaszkicwicz T, van Dongen JJM, Pieters R, Figdor CG, Hooftman A, Pals ST: Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. Leukemia 1990:4:383-389.
69. Huct S, Groux H, Caillou B, Valentin H, Prieur AM, Bernard A: CD44 contributes to T cell activation. J Immunol 1989;143:798-801.
70. Shimizu Y, van Seventer GA, Siraganian R, Wahl SL, Shaw S: Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 1989;143:2457-2463.
71. Denning SM, Le PT, Singer K.H, Haynes BF: Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 1990;144:7-15.
72. Pierres A, Lipcey C, Mawas C, Olive D: A unique CD44 monoclonal antibody identifies a new T cell activation pathway. Eur J Immunol 1992;22:413-417.
73. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A: CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995;128:687-698.
74. Bartolazzi A, Jackson D, Bennett K, Aruffo A, Dickinson R, Shields J, Whittle N, Stamcnkov-ic I: Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci 1995;108:1723-1733.
75. Jalkancn S, Joensuu H, Klemi P: Prognostic value of lymphocyte homing receptor and S value in non-Hodgkin’s lymphoma. Blood 1990;75:1549-1556.
76. Terpe HJ, Koopmann R, Imhof BA, Gunthert U: Expression of integrins and CD44 isoforms in non-Hodgkin’s lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J Pathol 1994; 174:89-100.
77. Stauder R, Eisterer W, Thaler J, Gunthert U: CD44 variant isoforms in non-Hodgkin’s lymphoma: A new independent prognostic factor. Blood 1995;85:2885-2899